Sinopharm Group HK$10 billion (US$1.3 billion) IPO
Bookrunners: CICC; Morgan Stanley; UBS
After a sluggish start to the year, a number of prominent initial public offerings (IPOs) were conducted during 2009. Two in particular stand out: Sinopharm’s Hong Kong listing and Maxis’ re-listing on the Bursa Malaysia.
Please take a trial or subscribe to access this content.
Contact Mark Goodes to discuss your access: firstname.lastname@example.org